U.S. Gives Opinion On Qui Tam Pfizer Suit
The government has weighed in on Pfizer Inc.'s bid to dismiss a whistleblower lawsuit filed by a former executive alleging that the company illegally marketed human growth hormone Genotropin....To view the full article, register now.
Already a subscriber? Click here to view full article